Lungs & Airways

Patient input needed for an updated Cochrane review on the effectiveness of inhaled steroids for stable COPD

Skills / interests: Consumer (public, patient, carer) input

Overview

This systematic review examines the benefits and safety of inhaled steroids for people with chronic obstructive pulmonary disease (COPD). Inhaled steroids alone are no longer recommended for people with COPD (known as “monotherapy”), but they are given in combination with other long-acting inhaled medicines. This review of inhaled steroids as monotherapy has been updated to help resolve ongoing uncertainties about their role in this population. The review analysed the effects of inhaled steroids on frequency of flare-ups ('exacerbations'), quality of life, breathing capacity, death rates and adverse events such as pneumonia.

Ideal applicant

We would like to hear from adults who have a diagnosis of COPD, particularly stable COPD. We are also pleased to receive input from carers of adults with the condition.

Think you've got what it takes to get the job done for Emma?

Log in
to respond

Questions & comments